Year in Review: Opyl (ASX:OPL) with CEO, Michelle Gallaher

Stockhead’s Year in Review video series is a yearly wrap up address from company leaders showcasing latest achievements, discoveries and developments of emerging ASX companies. 

In this instalment Michelle Gallaher, CEO at Opyl (ASX:OPL) takes a look back on the company’s achievements in 2022.

Opyl are a Melbourne based company that provides biopharma and health organisations access to emerging AI-assisted technologies and professional guidance to understand and improve healthcare design, development and delivery.

To hear about the company’s 2022 highlights, click above. 

Related Topics

Explore more

Explore more

Investor Guide: Health & Biotech FY2025 featuring Tim Boreham

Read The Guide